Validity Attack on US Patent for Bifidobacetrium Combo-Therapy: What can we learn?
Although the April 15, 2020 decision of the U.S. Patent Trial and Appeal Board (PTAB) was to invalidate The University of Chicago’s US microbiome patent, much can be learned and some positive notes echo from […]
